Why we get diarrhea

June 14, 2017
In the absence of claudin-2, clearance of C. rodentium (red) is impaired and bacteria are able to invade the normally-protected colonic crypt lumen. F-actin (green) and DNA (blue). Credit: Turner laboratory at Brigham and Women's Hospital.

Researchers want to know: does diarrhea serve a purpose? Does it actually help clear the bacteria causing a gastrointestinal infection, or is it merely a symptom of disease that should be prevented as much as possible? In a new study from Brigham and Women's Hospital, investigators explore the immune mechanism that drives diarrhea, concluding that it does play a critical role in pathogen clearance in the early stages of infection. The new study, published today in Cell Host and Microbe, also uncovers a previously unrecognized role for interleukin-22, an immune system molecule, in the host's defense against infection.

"The hypothesis that diarrhea clears intestinal pathogens has been debated for centuries," said corresponding author Jerrold Turner, MD, PhD, of the BWH Departments of Pathology and Medicine. "Its impact on the progression of remains poorly understood. We sought to define the role of diarrhea and to see if preventing it might actually delay pathogen clearance and prolong disease."

To investigate, researchers used a mouse model infected with Citrobacter rodentium, the mouse equivalent of an E. coli . Using this model, they saw an increase in the permeability of the intestinal barrier within just two days of infection—well before inflammation and epithelial damage. In particular, they uncovered a critical role for interleukin-22 that in turn influences another molecule called claudin-2, previously known to be involved in causing diarrhea. They found that diarrhea resulting from the signaling of these two molecules helped promote pathogen clearance and limited disease severity.

Other investigators have proposed developing new therapeutics to inhibit claudin-2. However, Turner and colleagues explain that the activation of this pathway may be critical for combating an infection, particularly in the early stages of a disease. They conclude that is critical to enteric pathogen clearance, and that IL-22 may play a key role in host defense.

Explore further: Microbiologists discover how gut bacterial resources are hijacked to promote intestinal illnesses

More information: Cell Host and Microbe (2017). DOI: 10.1016/j.chom.2017.05.009

Related Stories

Microbiologists discover how gut bacterial resources are hijacked to promote intestinal illnesses

December 10, 2014
UT Southwestern Medical Center microbiologists have identified key bacteria in the gut whose resources are hijacked to spread harmful foodborne E. coli infections and other intestinal illnesses.

Study suggests how flu-related gastrointestinal flare-ups can be relieved while body continues to battle virus the lung

November 3, 2014
Flu infection has long-ranging effects beyond the lung that can wreak havoc in the gut and cause a dreaded symptom, diarrhea, according to a study published in The Journal of Experimental Medicine.

Researchers identify a potential new therapeutic target for E. coli infections

March 28, 2013
(Medical Xpress)—A new study by researchers at the Center for Modeling Immunity to Enteric Pathogens at Virginia Bioinformatics Institute provides novel insight into how an emerging strain of the diarrhea-causing bacteria ...

Controlling levels of specific gut bacteria could help prevent severe diarrhea

November 10, 2015
Everyone has suffered from it. It's ranged from mild to severe. It's a condition that's most-often described in a whisper.

Recommended for you

New cellular approach found to control progression of chronic kidney disease

December 15, 2017
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage ...

Testing shows differences in efficacy of Zika vaccines after one year

December 15, 2017
(Medical Xpress)—A large team of researchers with members from Harvard Medical School, Walter Reed Army Institute of Research, Bioqual Inc. and MIT has found that the efficacy of the three types of Zika vaccines currently ...

How to regulate fecal microbiota transplants

December 15, 2017
(Medical Xpress)—A small team of researchers at the University of Maryland, some with affiliations to the Veterans Affairs Maryland Health Care System, has written and published a Policy Forum piece in the journal Science ...

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

Aging impairs innate immune response to flu

December 13, 2017
Aging impairs the immune system's response to the flu virus in multiple ways, weakening resistance in older adults, according to a Yale study. The research reveals why older people are at increased risk of illness and death ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.